Annual Non Current Assets
$217.41 M
+$136.28 M+167.99%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual long term assets is $217.41 million, with the most recent change of +$136.28 million (+167.99%) on December 31, 2022.
- During the last 3 years, EGRX annual non current assets has risen by +$142.30 million (+189.47%).
- EGRX annual non current assets is now at all-time high.
Performance
EGRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$217.57 M
-$4.11 M-1.85%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly long term assets is $217.57 million, with the most recent change of -$4.11 million (-1.85%) on June 30, 2023.
- Over the past year, EGRX quarterly non current assets has increased by +$30.27 million (+16.16%).
- EGRX quarterly non current assets is now -1.85% below its all-time high of $221.68 million, reached on March 31, 2023.
Performance
EGRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
EGRX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +168.0% | +16.2% |
| 3 y3 years | +189.5% | +146.5% |
| 5 y5 years | +167.2% | +200.8% |
EGRX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +168.0% | -1.9% | +172.0% |
| 5 y | 5-year | at high | +189.5% | -1.9% | +189.7% |
| alltime | all time | at high | >+9999.0% | -1.9% | >+9999.0% |
Eagle Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $217.57 M(-1.9%) |
| Mar 2023 | - | $221.68 M(+2.0%) |
| Dec 2022 | $188.75 M(+9.4%) | $217.41 M(+7.9%) |
| Sep 2022 | - | $201.40 M(+7.5%) |
| Jun 2022 | - | $187.30 M(+134.1%) |
| Mar 2022 | - | $80.00 M(-1.4%) |
| Dec 2021 | $172.61 M(+3.9%) | $81.13 M(-4.1%) |
| Sep 2021 | - | $84.57 M(-4.7%) |
| Jun 2021 | - | $88.74 M(-7.5%) |
| Mar 2021 | - | $95.98 M(+10.2%) |
| Dec 2020 | $166.06 M(-7.5%) | $87.13 M(+3.3%) |
| Sep 2020 | - | $84.36 M(-4.4%) |
| Jun 2020 | - | $88.27 M(+2.2%) |
| Mar 2020 | - | $86.37 M(+15.0%) |
| Dec 2019 | $179.45 M(+9.5%) | $75.11 M(-2.8%) |
| Sep 2019 | - | $77.25 M(+1.7%) |
| Jun 2019 | - | $75.97 M(-1.6%) |
| Mar 2019 | - | $77.22 M(+3.3%) |
| Dec 2018 | $163.84 M | $74.76 M(+5.3%) |
| Sep 2018 | - | $71.02 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $72.34 M(-10.1%) |
| Mar 2018 | - | $80.48 M(-1.1%) |
| Dec 2017 | $188.70 M(+72.9%) | $81.36 M(-4.0%) |
| Sep 2017 | - | $84.74 M(-12.0%) |
| Jun 2017 | - | $96.31 M(-4.9%) |
| Mar 2017 | - | $101.25 M(-3.8%) |
| Dec 2016 | $109.11 M(-10.8%) | $105.21 M(+280.1%) |
| Sep 2016 | - | $27.68 M(+99.6%) |
| Jun 2016 | - | $13.87 M(-1.5%) |
| Mar 2016 | - | $14.08 M(+499.6%) |
| Dec 2015 | $122.26 M(+130.6%) | $2.35 M(+22.7%) |
| Sep 2015 | - | $1.91 M(+300.4%) |
| Jun 2015 | - | $478.00 K(+229.7%) |
| Mar 2015 | - | $145.00 K(-62.5%) |
| Dec 2014 | - | $387.00 K(-0.5%) |
| Sep 2014 | $53.02 M(+203.3%) | $389.00 K(-3.8%) |
| Jun 2014 | - | $404.50 K(-4.3%) |
| Mar 2014 | - | $422.50 K(-60.7%) |
| Dec 2013 | - | $1.07 M(+73.3%) |
| Sep 2013 | $17.48 M(+97.2%) | $620.00 K |
| Sep 2012 | $8.87 M | - |
FAQ
- What is Eagle Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual non current assets year-on-year change?
- What is Eagle Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly non current assets year-on-year change?
What is Eagle Pharmaceuticals annual long term assets?
The current annual non current assets of EGRX is $217.41 M
What is the all time high annual non current assets for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual long term assets is $217.41 M
What is Eagle Pharmaceuticals annual non current assets year-on-year change?
Over the past year, EGRX annual long term assets has changed by +$136.28 M (+167.99%)
What is Eagle Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of EGRX is $217.57 M
What is the all time high quarterly non current assets for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly long term assets is $221.68 M
What is Eagle Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, EGRX quarterly long term assets has changed by +$30.27 M (+16.16%)